Current situation and development of prenatal diagnosis in China

Frontiers of Medicine in China

Volumn 4, Issue 3, 2010, Pages 271-274

  Bian, Xu Ming ^a   Guo, Qi ^a   Qi, Qing Wei ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

China; prenatal diagnosis; prenatal screening

Indexed keywords

AMNIOCENTESIS; CHINA; CHROMOSOME ABERRATION; CONGENITAL DISORDER; ETHICS; FEMALE; FETUS DISEASE; FETUS ECHOGRAPHY; GENETIC DISORDER; HUMAN; PREGNANCY; PRENATAL DEVELOPMENT; PRENATAL DIAGNOSIS; REVIEW; STATISTICS;

AMNIOCENTESIS; CHINA; CHROMOSOME ABERRATIONS; CONGENITAL ABNORMALITIES; FEMALE; FETAL DISEASES; GENETIC DISEASES, INBORN; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS; ULTRASONOGRAPHY, PRENATAL;

EID: 77956648727     PISSN: 16737342     EISSN: 16737458     Source Type: Journal    
DOI: 10.1007/s11684-010-0100-z     Document Type: Review

References (9)

1. Bian XM, Liu J T, Qi Q W, Jiang Y L, Li Y, Liu S Y, Hao N, Zhou J, Lü SM, Zhu B S, Wang H, Xu Z F, Pan X Y, Liao C, Cai Y, Wang H, Wang Z, Zhu J, Hu Y L. Second trimester maternal serum screening for Down's syndrome in mainland China: a multi-center prospective study. Zhonghua Fu Chan Ke Za Zhi, 2008, 43(11): 805-809 (in Chinese).
2. Cowans N J, Spencer K. First-trimester ADAM12 and PAPP-A as markers for intrauterine fetal growth restriction through their roles in the insulin-like growth factor system. Prenat Diagn, 2007, 27(3): 264-271.
3. Wald N J, Rodeck C, Hackshaw A K, Rudnicka A. SURUSS in perspective. BJOG, 2004, 111(6): 521-531.
4. Malone F D, Canick J A, Ball R H, Nyberg D A, Comstock C H, Bukowski R, Berkowitz R L, Gross S J, Dugoff L, Craigo S D, Timor-Tritsch I E, Carr S R, Wolfe H M, Dukes K, Bianchi D W, Rudnicka A R, Hackshaw A K, Lambert-Messerlian G, Wald N J, D'Alton M E; First- and Second-Trimester Evaluation of Risk (FASTER) Research Consortium. First-trimester or second-trimester screening, or both, for Down's syndrome. New Engl J Med, 2005, 353(19): 2001-2011.
5. Poon L L, Leung T N, Lau T K, Chow K C, Lo Y M D. Differential DNA methylation between fetus and mother as a strategy for detecting fetal DNA in maternal plasma. Clin Chem, 2002, 48(1): 35-41.
6. Li L, Zhou Y Q, Xiao Q Z, Yan T Z, Xu X M. Development and evaluation of a reverse dot blot assay for the simultaneous detection of six common Chinese G6PD mutations and one polymorphism. Blood Cells Mol Dis, 2008, 41(1): 17-21.
7. Yi P, Yu F, Huang S, Zhong C, Li Q, Yang Y, Zhang W, Xiao C, Xu X. Identification of a novel frameshift mutation at codon 53 (-T) in the beta-globin gene causing dominantly inherited beta-thalassemia in a Chinese Miao family. Blood Cells Mol Dis, 2008, 41(1): 56-59.
8. Zeng F, Ren Z R, Huang S Z, Kalf M, Mommersteeg M, Smit M, White S, Jin C L, Xu M, Zhou D W, Yan J B, Chen M J, van Beuningen R, Huang S Z, den Dunnen J, Zeng Y T, Wu Y. Array-MLPA: comprehensive detection of deletions and duplications and its application to DMD patients. Hum Mutat, 2008, 29(1): 190-197.
9. Yin S, Na Q, Chen J, Li-Ling J, Liu C. Contribution of MRI to detect further anomalies in fetal ventriculomegaly. Fetal Diagn Ther, 2010, 27(1): 20-24.